Bio-Techne Corporation (TECH)
NASDAQ · Healthcare
Bio-Techne Corporation Shareholder Equity 2009–2025
Bio-Techne Corporation annual shareholder equity history from 2009 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Bio-Techne Corporation shareholder equity as of June 30, 2025: 1.92B, a 7.25% decrease year-over-year.
- Bio-Techne Corporation shareholder equity for 2025 were 1.92B, a 7.25% decrease from 2024.
- Bio-Techne Corporation shareholder equity for 2024 were 2.07B, a 5.20% increase from 2023.
- Bio-Techne Corporation shareholder equity for 2023 were 1.97B, a 15.56% increase from 2022.
- Bio-Techne Corporation shareholder equity for 2022 were 1.70B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Bio-Techne Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,919 |
| 2024 | $2,069 |
| 2023 | $1,967 |
| 2022 | $1,702 |
| 2021 | $1,563 |
| 2020 | $1,381 |
| 2019 | $1,166 |
| 2018 | $1,079 |
| 2017 | $950 |
| 2016 | $879 |
| 2015 | $847 |
| 2014 | $795 |
| 2013 | $738 |
| 2012 | $674 |
| 2011 | $586 |
Bio-Techne Corporation Shareholder Equity — FAQ
Bio-Techne Corporation (TECH) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TECH's shareholder equity history?
The chart and table above show Bio-Techne Corporation's shareholder equity by year and by quarter, including the growth rate.